Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting.
This paper describes the development of nonmyeloablative marrow transplant programs that have little toxicity in a canine model and their translation to patients with malignant and nonmalignant hematological diseases.
Storb
R
R
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. rstorb@fhcrc.org
Yu
C
C
Sandmaier
B M
BM
McSweeney
P A
PA
Georges
G
G
Nash
R A
RA
Woolfrey
A
A
D000553:Ambulatory Care; D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy; D016026:Bone Marrow Transplantation / Q000502:physiology*; D004285:Dogs; D006402:Hematologic Diseases / Q000628:therapy; D019337:Hematologic Neoplasms / Q000628:therapy; D006412:Hematopoietic Stem Cells / Q000502:physiology*; D006801:Humans; D018183:Transplantation Chimera; D014184:Transplantation, Homologous / Q000502:physiology